{"id":"W4388341977","doi":"10.1016/j.ctrv.2023.102652","title":"Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review","year":2023,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Ipsen; Ipsen Fund","keywords":"Medicine; Cabozantinib; Tolerability; Pazopanib; Renal cell carcinoma; Oncology; Internal medicine; Vascular endothelial growth factor; Adverse effect; Systematic review; Regimen; Cochrane Library; Sunitinib; MEDLINE; Randomized controlled trial; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009150035,0.00135004,0.008171307,0.01148207,0.0006099043,0.002281174,0.001794965,0.001788612,0.004145905],"category_scores_gemma":[0.03815167,0.0009771348,0.007007205,0.0111733,0.0008355902,0.002264751,0.001270589,0.0008793515,0.0002829975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003728258,"about_ca_system_score_gemma":0.01302417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007042616,"about_ca_topic_score_gemma":0.0193996,"domain_scores_codex":[0.9921919,0.002684233,0.003171001,0.0006767737,0.001046455,0.0002296652],"domain_scores_gemma":[0.9732718,0.01721144,0.006546131,0.0003782691,0.002318483,0.0002739361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000122171,0.00001019161,0.0007810701,0.9755839,0.005832119,0.00006147586,0.00009787046,0.00006340705,0.0001053707,0.000105343,0.0007229248,0.01651413],"study_design_scores_gemma":[0.0002772084,0.0002226101,0.004292794,0.9234613,0.06069087,0.0003379126,0.0001947275,0.0000798613,0.0001347647,0.0002264212,0.01005129,0.00003039153],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001636898,0.9965932,0.0001586932,0.0002748739,0.00009217849,0.0004291439,0.0005720417,0.000008205114,0.0002347984],"genre_scores_gemma":[0.02177965,0.9747838,0.000931338,0.0007026063,0.0001078408,0.001177363,0.0003938874,0.000005680266,0.0001179016],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01148207,"threshold_uncertainty_score":0.04839057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03545536927305138,"score_gpt":0.285767195707976,"score_spread":0.2503118264349246,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}